• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ABLX:BB

8.3250 EUR 0.0480 0.58%

As of 11:35:00 ET on 09/23/2014.

Snapshot for Ablynx NV (ABLX)

Open: 8.3100 Day's Range: 8.2610 - 8.3890 Volume: 45,763
Previous Close: 8.2770 52wk Range: 6.6000 - 10.1800 1-Yr Rtn: +0.67%

Stock Chart for ABLX

No chart data available.
  • ABLX:BB 8.3250
  • 1D
  • 1M
  • 1Y
8.2770
Interactive ABLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ABLX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. BEL20 -
Earnings Per Share (EUR) (ttm) -0.3200
Est. EPS (EUR) (12/2014) -0.2420
Est. PEG Ratio -
Market Cap (M EUR) 447.03
Shares Outstanding (M) 54.00
30 Day Average Volume 47,449
Price/Book (mrq) 9.9047
Price/Sale (ttm) 9.3323
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ABLX

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ABLX

Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.

Edwin MosesChief Executive OfficerWim OttevaereChief Financial Officer
Josefin-Beate Holz "Josi"Chief Medical OfficerMarieke VermeerschAssociate Dir:Investor Relations
More Company Profile & Key Executives for ABLX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil